Ausgabe 4/2016
Challenges and Controversies in Translational Stroke Research
Inhalt (11 Artikel)
Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines
Johannes Boltze, Daniel-Christoph Wagner, Nils Henninger, Nikolaus Plesnila, Cenk Ayata
Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes
Adviye Ergul, Sherif Hafez, Abdelrahman Fouda, Susan C. Fagan
The Importance of Considering Sex Differences in Translational Stroke Research
Hilda Ahnstedt, Louise D. McCullough, Marilyn J. Cipolla
Embracing Biological and Methodological Variance in a New Approach to Pre-Clinical Stroke Testing
Thomas A. Kent, Pitchaiah Mandava
Extending the Time Window for Endovascular and Pharmacological Reperfusion
Nils Henninger, Marc Fisher
Improving Reperfusion Therapies in the Era of Mechanical Thrombectomy
Italo Linfante, Marilyn J. Cipolla
Strain-Related Differences in the Immune Response: Relevance to Human Stroke
Kyra J. Becker
Regulatory T Cells in Post-stroke Immune Homeostasis
Arthur Liesz, Christoph Kleinschnitz
Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke Model
Bing Yang, Kaushik Parsha, Krystal Schaar, XiaoPei Xi, Jaroslaw Aronowski, Sean I. Savitz
Translational Hurdles in Stroke Recovery Studies
Jukka Jolkkonen, Gert Kwakkel
Academic-industry Collaborations in Translational Stroke Research
Johannes Boltze, Daniel-Christoph Wagner, Henryk Barthel, Matthew J. Gounis